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The etiology of granuloma annulare (GA) remains unknown, although several eliciting factors have been
proposed. We herein present the case of an 81-year-old man who developed generalized erythematous
annular plaques 6 months after engraftment of a vascular stent for abdominal aneurysm repair. Based on
the diagnosis of generalized GA and the patient's age, we treated him with psoralens plus ultraviolet A
therapy. The treatment response was good. This is the ﬁrst report showing the association between
vascular stent and generalized GA.
Copyright © 2014, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. All rights reserved.Introduction
The etiology of granuloma annulare (GA) remains unknown,
although several eliciting factors have been proposed. We present
the case of an 81-year-old man who developed generalized
erythematous annular plaques 6 months after engraftment of a
vascular stent for abdominal aneurysm repair. Based on the diag-
nosis of generalized GA and the patient's age, he was treated with
psoralens plus ultraviolet A (PUVA) therapy. Good response was
achieved following the therapy.
Case report
An 81-year-old man developed generalized asymptomatic papules
and plaques on his elbow, back, forearms, and chest, which had
persisted for 6 months. He had no recent contact or major incidents
related to this presentation. The levels of tumor markers, including
carcinoembryonic antigen, alpha-fetoprotein, and prostate-speciﬁc
antigen, were all within normal limit. The patient had hyperten-
sion, which was under regular medical control [amlodipine (5 mg)
and isosorbide (30 mg/day)] for more than 5 years without anyy have no ﬁnancial or non-
atter or materials discussed
logy, Chang Gung Memorial
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, Taiwan.
cal Association. Published by Elsevchange in the treatment regimen. However, chest and abdominal
computed tomography revealed no occult malignancy except a
rapidly growing abdominal aortic aneurysm. He received endo-
vascular aneurysm repair, during which a 28-mm endovascular
stent graft (Gore Medical Products, Flagstaff, AZ, USA) was inserted
in January 2013. Six months later, skin lesions started to develop.
Dermatological examination revealed multiple discrete, small,
ﬂesh-colored to erythematous annular plaques with central invo-
lution on the trunk and limbs (Figure 1AeC). Skin biopsy showed
multiple noncaseating, palisading granulomas with central necro-
biosis from the superﬁcial to deep dermis with surrounding in-
ﬁltrates of histiocytes, multinucleated giant cells, and few
lymphocytes (Figure 2). Mucin deposition was evident on hema-
toxylineeosin and Alcian blue staining. Generalized GA was diag-
nosed. Considering the diffuse nature of the lesions and the
patient's age, he was treated with PUVA therapy (oral methoxsalen
20 mg three times weekly and UVA). Good response was
achieved after 16 treatments with a cumulative dose of 58.5 J/cm2
(Figure 3). No recurrence was observed from 10 months of follow-
up to date.
Discussion
GA is usually a self-limiting disease. At present, the etiology of GA
remains unknown, although several eliciting factors such as
trauma, drugs, and infections have been reported.1,2 Generalized GA
is a rare variant among all subtypes.3 In particular, generalized GA
has been reported to be associated with diabetes mellitus, dysli-
pidemia, chronic hepatitis C infection, autoimmune thyroidier Taiwan LLC. All rights reserved.
Figure 1 (A) Multiple annular erythematous plaques on the forearms. (B) Numerous annular plaques on the back. (C) A closer look showed the annular erythematous plaque with
elevated border.
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tween microangiopathy, autoimmune vasculitis, and abnormal
delayed-type hypersensitivity (DTH) in generalized GA suggests the
involvement of abnormal T-cell and granulation responses to
certain external and/or self-antigens.5 In this case, the patient un-
derwent vascular graft placement 6 months before the skin erup-
tions developed. The graft placed within the vessel was composed
of thromboresistant heparin coating on the luminal side, alongwith
a synthetic vascular stent. The drug coating on the stent and/or the
metallic content of the stent could trigger DTH.6 In fact, various
reports suggest that cutaneous adverse hypersensitivity reactions
occur in around 7.5% of patients receiving heparin treatment.
Among these, DTH is the most common skin reaction related toFigure 2 Skin biopsy showed characteristic palisading granuloma with central nec-
robiosis admixed with mucinous stroma (hematoxylin and eosin stain, 40).
Figure 3 The skin lesions were barely visible 10 months after the psoralens plus ul-
traviolet A therapy.
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and the host immune system might have generated hypersensi-
tivity and granulomatous responses to form the granulomas. Based
on the literatures reviewed, this is the ﬁrst report of a generalized
GA associated with synthetic vascular stent implantation.
Treatment of generalized GA should be directly based on pa-
tient's age, sites of involvement, and host immune status. PUVA, in
oral and bath forms, has been evaluated and proven to be effective
for generalized GA in antecedent reports.8 The success of PUVA
therapy in our case may be credited to the immunomodulatory
mechanism affecting the inﬂammatory cells, keratinocytes, and
ﬁbroblasts.Conclusion
The case has offered a possible association between generalized
annulare and synthetic vascular stent for abdominal aneurysmrepair. The case also emphasized the good efﬁcacy and safety of
PUVA as a successful treatment option.
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